295 related articles for article (PubMed ID: 1865418)
1. Rheumatic manifestations in myelodysplastic syndromes.
Castro M; Conn DL; Su WP; Garton JP
J Rheumatol; 1991 May; 18(5):721-7. PubMed ID: 1865418
[TBL] [Abstract][Full Text] [Related]
2. Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases.
Kuzmich PV; Ecker GA; Karsh J
J Rheumatol; 1994 Sep; 21(9):1649-54. PubMed ID: 7799343
[TBL] [Abstract][Full Text] [Related]
3. [A case of malignant rheumatoid arthritis associated with myelodysplastic syndrome].
Hisakawa N; Nishiya K; Hashimoto K; Tanaka Y
Ryumachi; 1997 Feb; 37(1):30-5. PubMed ID: 9128421
[TBL] [Abstract][Full Text] [Related]
4. [Vasculitis associated with a myelodysplastic syndrome: a report of 5 cases].
Fernández-Miranda C; García-Marcilla A; Martín M; Gil R; Vanaclocha F; Torres N; del Palacio A
Med Clin (Barc); 1994 Oct; 103(14):539-42. PubMed ID: 7799667
[TBL] [Abstract][Full Text] [Related]
5. Childhood myelodysplastic syndromes in a Brazilian population.
Lopes LF; Lorand-Metze I
Pediatr Hematol Oncol; 1999; 16(4):347-53. PubMed ID: 10407872
[TBL] [Abstract][Full Text] [Related]
6. Rheumatic manifestations of neoplasia.
Brooks PM
Curr Opin Rheumatol; 1992 Feb; 4(1):90-3. PubMed ID: 1543670
[TBL] [Abstract][Full Text] [Related]
7. Large-vessel arteritis and myelodysplastic syndrome: report of two cases.
Steurer M; Fritsche G; Tzankov A; Gotwald T; Sturm W; Konwalinka G; Gruber J
Eur J Haematol; 2004 Aug; 73(2):128-33. PubMed ID: 15245512
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic manifestations in myelodysplastic syndrome].
Loraas A; Lamvik J; Matre J
Tidsskr Nor Laegeforen; 1994 May; 114(14):1609-11. PubMed ID: 8079262
[TBL] [Abstract][Full Text] [Related]
9. Vasculitides associated with malignancies: analysis of sixty patients.
Fain O; Hamidou M; Cacoub P; Godeau B; Wechsler B; Pariès J; Stirnemann J; Morin AS; Gatfosse M; Hanslik T; Belmatoug N; Blétry O; Cevallos R; Delevaux I; Fisher E; Hayem G; Kaplan G; Le Hello C; Mouthon L; Larroche C; Lemaire V; Piette AM; Piette JC; Ponge T; Puechal X; Rossert J; Sarrot-Reynauld F; Sicard D; Ziza JM; Kahn MF; Guillevin L
Arthritis Rheum; 2007 Dec; 57(8):1473-80. PubMed ID: 18050165
[TBL] [Abstract][Full Text] [Related]
10. [Collagen diseases complicated with myelodysplastic syndrome (MDS)--report of three cases].
Takashima H; Eguchi K; Origuchi T; Yamasita I; Nakashima M; Ida H; Sakai M; Simada H; Kawabe Y; Nagataki S
Ryumachi; 1994 Feb; 34(1):48-53. PubMed ID: 8146728
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
12. The dual association between lymphoma and autoimmunity.
Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients.
Dalamaga M; Karmaniolas K; Matekovits A; Migdalis I; Papadavid E
J Eur Acad Dermatol Venereol; 2008 May; 22(5):543-8. PubMed ID: 18070024
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndrome with erythroid hypoplasia: a rare and distinct clincopathological entity--a report of two cases.
Kumar V; Dash S
Indian J Pathol Microbiol; 2005 Jan; 48(1):36-7. PubMed ID: 16758786
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
Yee KW; Zeng Z; Konopleva M; Verstovsek S; Ravandi F; Ferrajoli A; Thomas D; Wierda W; Apostolidou E; Albitar M; O'Brien S; Andreeff M; Giles FJ
Clin Cancer Res; 2006 Sep; 12(17):5165-73. PubMed ID: 16951235
[TBL] [Abstract][Full Text] [Related]
16. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
[TBL] [Abstract][Full Text] [Related]
17. An association of polymyalgia rheumatica with myelodysplastic syndromes.
Kohli M; Bennett RM
J Rheumatol; 1994 Jul; 21(7):1357-9. PubMed ID: 7966085
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
19. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
Di Giovanni S; Giallonardo P; Costa MP; Carducci P
Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
[No Abstract] [Full Text] [Related]
20. Pathologic sideroblastosis in myelodysplastic syndromes and acute nonlymphocytic leukemia.
Bernardeschi P; Bonechi I
Recenti Prog Med; 1991 Nov; 82(11):588-90. PubMed ID: 1763231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
